METHOD OF SUBRETINAL NEOVASCULAR MEMBRANE TREATMENT Russian patent published in 2009 - IPC A61F9/00 A61N5/67 A61K31/409 A61K35/14 A61P27/02 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, ophthalmology, and can be applied for treatment of subretinal neovascular membrane. For this purpose intravenously introduced is preparation "Photosens" 0.01-0.1 mg/kg of weight 10-20 hours before laser exposure. Laser exposure is realised on subretinal neovascular membrane with wave length corresponding to peak of absorption of photosensitiser with total light doze 300-500 J/cm² one time in 24-hours per course of 1-5 sessions. 48 hours after laser exposure medicine which blocks growth factor of vessel endothelium is introduced endovitreally one time.

EFFECT: method allows to obtain complete desolation of neogenic vessels net and prevent relapse of SNM growing in presence of maximal preservation of surrounding tissues, neuroepithelium and retinal pigment epithelium.

2 cl, 4 dwg, 2 ex